Related Experiment Video
Updated: Feb 25, 2026
Live-Cell Imaging Assays to Study Glioblastoma Brain Tumor Stem Cell Migration and Invasion
Published on: August 29, 2018
Cancer stem cell markers in glioblastoma - an update
1Department of Neurosurgery, Affiliated Xuzhou Hospital of Southeast University, Xuzhou, Jiangsu Province, China. xhs51@126.com.
Abstract:
The glioblastoma includes brain tumors, which are very aggressive in nature and are among the most common brain tumors in adults. Latest therapeutic avenues involve combination approach. However, the observed median survival is still no more than 15 months. Moreover, there is a scarcity of accurate pre-clinical model systems, which in turn resulted in limited treatment options for this disease. Cancer stem cells are attractive avenues in anticancer research against glioblastoma. Most of the recent studies are focused towards the identification of novel markers for cancer stem cells. The present review article is focused on two important markers in current research viz. Prominin-1 and NPM1 in glioblastoma.
Insights
Glioblastoma, a common aggressive brain tumor, has limited treatment options. This review highlights Prominin-1 and NPM1 as key cancer stem cell markers for glioblastoma research.
Area of Science:
- Neuro-oncology
- Cancer Stem Cell Biology
Background:
- Glioblastoma is a highly aggressive primary brain tumor in adults with poor median survival rates.
- Current treatment strategies offer limited efficacy, partly due to a scarcity of accurate preclinical models.
- Cancer stem cells (CSCs) represent a promising therapeutic target for glioblastoma.
Purpose of the Study:
- To review the significance of cancer stem cell markers in glioblastoma research.
- To focus on Prominin-1 and NPM1 as critical markers in current glioblastoma studies.
Main Methods:
- Literature review of recent studies on glioblastoma and cancer stem cell markers.
- Analysis of research focusing on Prominin-1 and NPM1 in glioblastoma contexts.
Main Results:
- Cancer stem cells are crucial targets for novel glioblastoma therapies.
- Prominin-1 and NPM1 are identified as important markers for glioblastoma stem cells.
- Further research into these markers may improve preclinical models and treatment options.
Conclusions:
- Targeting glioblastoma cancer stem cells holds therapeutic potential.
- Prominin-1 and NPM1 are key areas of investigation for improving glioblastoma treatment strategies.
Related Concept Videos
02:40Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
01:18Distinctive Features of Adult Stem Cells vs Cancer Stem Cells
Adult stem cells
Adult stem cells are tissue-specific; hence, they divide to develop the tissue from which they originate. One type of adult stem cell is the epithelial stem cell, which gives rise to the keratinocytes in the multiple layers of epithelial cells in the epidermis of the skin. Adult bone marrow has three distinct types of stem cells:...